On Monday, December 11, from 8:00am-5:00pm, we will perform annual maintenance of our website. During this time, some website functionality will be unavailable. Once complete, anything related to the 2023 session will be moved to the Archives. Mahalo for your understanding!

2024 HOUSE AND SENATE SESSION JOB OPPORTUNITIES AVAILABLE NOW

2017 Archives
You are viewing archived information from 2017
SB504     
Measure Title: RELATING TO CONTROLLED SUBSTANCES.
Report Title: Controlled Substances; Opioids; Benzodiazepines; Initial Prescription
Description: Limits initial prescriptions for opioids and benzodiazepines to a maximum of seven consecutive days.
Companion:  HB666
Package: Women's Legislative Caucus
Current Referral: CPH
Introducer(s): BAKER, GREEN, INOUYE, KEITH-AGARAN, KIDANI, KIM, SHIMABUKURO, TOKUDA, S. Chang, Espero, Kouchi, L. Thielen
Act:

Sort by Date Status Text
1/31/2017SRe-Referred to CPH.
1/30/2017SThe committee(s) on PSM deleted the measure from the public hearing scheduled on 01-31-17 1:15PM in conference room 229.
1/27/2017SThe committee(s) on PSM has scheduled a public hearing on 01-31-17 1:15PM in conference room 229.
1/23/2017SReferred to PSM, CPH.
1/23/2017SPassed First Reading.
1/20/2017SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB504
All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Testimony
No testimony available at this time.

Hearing Notices
No hearings scheduled